Page 11 - Gamida Cell News Today

Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) saw a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 5,140,000 shares, a decline of 7.7% from the February 28th total of 5,570,000 shares. Approximately 9.8% of the shares of the company are short sold. Based on […]

Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) was the recipient of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 5,140,000 shares, a decline of 7.7% from the February 28th total of 5,570,000 shares. Approximately 9.8% of the shares of the company are short […]

Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) – Investment analysts at HC Wainwright issued their Q1 2023 earnings per share (EPS) estimates for shares of Gamida Cell in a research report issued to clients and investors on Tuesday, March 28th. HC Wainwright analyst V. Bernardino expects that the company will post earnings per share of […]

Gamida Cell (NASDAQ:GMDA – Get Rating) had its target price trimmed by Oppenheimer from $10.00 to $8.00 in a report released on Monday, The Fly reports. The firm currently has an outperform rating on the stock. Oppenheimer also issued estimates for Gamida Cell’s Q1 2023 earnings at ($0.28) EPS, Q2 2023 earnings at ($0.23) EPS, […]

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Gamida Cells Conference Call for the Full Year 2022 Financial Results.

Gamida Cell Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 79.38 million compared to USD 89.79 million a year ago.... | March 28, 2023

Real-time index price for Dow Jones Industrials Average (DOWI), along with buy or sell indicators, analysis, charts, historical performance, news and more

Company reports on productive interactions with FDA and preparations for launch of omidubicel, if approved, in advance of May 1 PDUFA date Company outlines strategic restructuring, plans to... | March 27, 2023

Gamida Cell (NASDAQ:GMDA – Get Rating) had its price objective cut by Oppenheimer from $10.00 to $8.00 in a report issued on Monday, The Fly reports. Gamida Cell Stock Down 49.6 % Shares of NASDAQ GMDA traded down $0.67 during midday trading on Monday, hitting $0.68. The company’s stock had a trading volume of 21,530,275 […]

Should You Buy or Sell Gamida Cell Stock? Get The Latest GMDA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.